» Articles » PMID: 25875958

Metabolic Plasticity in Resting and Thrombin Activated Platelets

Overview
Journal PLoS One
Date 2015 Apr 16
PMID 25875958
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that can be utilized to serve the energetic and metabolic needs for resting and thrombin-dependent platelet aggregation. Using platelets from healthy human donors, we found that there was a rapid thrombin-dependent increase in oxidative phosphorylation which required both glutamine and fatty acids but not glucose. Inhibition of fatty acid oxidation or glutamine utilization could be compensated for by increased glycolytic flux. No evidence for significant mitochondrial dysfunction was found, and ATP/ADP ratios were maintained following the addition of thrombin, indicating the presence of functional and active mitochondrial oxidative phosphorylation during the early stages of aggregation. Interestingly, inhibition of fatty acid oxidation and glutaminolysis alone or in combination is not sufficient to prevent platelet aggregation, due to compensation from glycolysis, whereas inhibitors of glycolysis inhibited aggregation approximately 50%. The combined effects of inhibitors of glycolysis and oxidative phosphorylation were synergistic in the inhibition of platelet aggregation. In summary, both glycolysis and oxidative phosphorylation contribute to platelet metabolism in the resting and activated state, with fatty acid oxidation and to a smaller extent glutaminolysis contributing to the increased energy demand.

Citing Articles

Platelets and mitochondria: the calcium connection.

Shehwar D, Barki S, Aliotta A, Calderara D, Veuthey L, Portela C Mol Biol Rep. 2025; 52(1):276.

PMID: 40029418 DOI: 10.1007/s11033-025-10389-3.


The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications.

Liu Y, Hu P, Cheng H, Xu F, Ye Y Front Neurol. 2025; 16:1514394.

PMID: 39926015 PMC: 11802445. DOI: 10.3389/fneur.2025.1514394.


Buyang Huanwu decoction ameliorates myocardial injury and attenuates platelet activation by regulating the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway.

Gao J, Guo H, Li J, Zhan M, You Y, Xin G Chin Med. 2024; 19(1):109.

PMID: 39160598 PMC: 11331649. DOI: 10.1186/s13020-024-00976-0.


Platelet Ido1 expression is induced during Plasmodium yoelii infection, altering plasma tryptophan metabolites.

Blick-Nitko S, Ture S, Schafer X, Munger J, Livada A, Li C Blood Adv. 2024; 8(22):5814-5825.

PMID: 39133890 PMC: 11609358. DOI: 10.1182/bloodadvances.2024013175.


Analysis of Cellular Stress Assay Parameters and Intracellular ATP in Platelets: Comparison of Platelet Preparation Methods.

Tessema B, Haag J, Sack U, Konig B Int J Mol Sci. 2024; 25(9).

PMID: 38732108 PMC: 11084208. DOI: 10.3390/ijms25094885.


References
1.
Marnett L, Rowlinson S, Goodwin D, Kalgutkar A, Lanzo C . Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J Biol Chem. 1999; 274(33):22903-6. DOI: 10.1074/jbc.274.33.22903. View

2.
Kantor P, Lucien A, Kozak R, Lopaschuk G . The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2000; 86(5):580-8. DOI: 10.1161/01.res.86.5.580. View

3.
Fukami M, Holmsen H, Salganicoff L . Adenine nucleotide metabolism of blood platelets. IX. Time course of secretion and changes in energy metabolism in thrombin-treated platelets. Biochim Biophys Acta. 1976; 444(3):633-43. DOI: 10.1016/0304-4165(76)90310-x. View

4.
Wanders R, Vreken P, Ferdinandusse S, Jansen G, Waterham H, van Roermund C . Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans. 2001; 29(Pt 2):250-67. DOI: 10.1042/0300-5127:0290250. View

5.
Yamagishi S, Edelstein D, Du X, Brownlee M . Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes. 2001; 50(6):1491-4. DOI: 10.2337/diabetes.50.6.1491. View